Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report

Keijiro Sato, Yoshitaka Zaimoku, Yui Kano, Miku Kobayashi, Shintaro Kazama, Takahiro Morikawa, Hiroko Kazumoto, Wataru Ishii, Toshimitsu Ueki, Masahiko Sumi, Hikaru Kobayashi, Yasuhito Nannya, Seishi Ogawa, Naoaki Ichikawa

Open source

DOI
10.3389/fimmu.2026.1841156
Published
2026-06-10
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1841156,
  title = {Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report},
  author = {Keijiro Sato and Yoshitaka Zaimoku and Yui Kano and Miku Kobayashi and Shintaro Kazama and Takahiro Morikawa and Hiroko Kazumoto and Wataru Ishii and Toshimitsu Ueki and Masahiko Sumi and Hikaru Kobayashi and Yasuhito Nannya and Seishi Ogawa and Naoaki Ichikawa},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1841156},
  url = {https://doi.org/10.3389/fimmu.2026.1841156}
}

RIS

TY  - JOUR
TI  - Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report
AU  - Keijiro Sato
AU  - Yoshitaka Zaimoku
AU  - Yui Kano
AU  - Miku Kobayashi
AU  - Shintaro Kazama
AU  - Takahiro Morikawa
AU  - Hiroko Kazumoto
AU  - Wataru Ishii
AU  - Toshimitsu Ueki
AU  - Masahiko Sumi
AU  - Hikaru Kobayashi
AU  - Yasuhito Nannya
AU  - Seishi Ogawa
AU  - Naoaki Ichikawa
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1841156
UR  - https://doi.org/10.3389/fimmu.2026.1841156
ER  - 

APA

Sato, K., Zaimoku, Y., Kano, Y., Kobayashi, M., Kazama, S., Morikawa, T., Kazumoto, H., Ishii, W., Ueki, T., Sumi, M., Kobayashi, H., Nannya, Y., Ogawa, S., & Ichikawa, N. (2026). Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1841156

Source records